DELAYED GRAFT FUNCTION
Clinical trials for DELAYED GRAFT FUNCTION explained in plain language.
Never miss a new study
Get alerted when new DELAYED GRAFT FUNCTION trials appear
Sign up with your email to follow new studies for DELAYED GRAFT FUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to wake up transplanted kidneys faster
Disease control TerminatedThis study tests a drug called pegcetacoplan in 320 adults who are getting a kidney transplant from a deceased donor and are at high risk for delayed graft function (when the kidney takes a while to start working). The goal is to see if the drug helps the kidney work sooner and r…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to kickstart kidneys after transplant
Disease control OngoingThis study tests a drug called ARGX-117 in people who get a kidney from a deceased donor and are at risk for delayed graft function (when the kidney takes time to start working). About 103 participants will receive either the drug or a placebo by IV. The goal is to see if the dru…
Matched conditions: DELAYED GRAFT FUNCTION
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC